May 3rd, 2017, Cedem AG began the precision medicine initiative in Jordan. An executive lunch was held at the King Hussein Club, where the OptiCancer project was presented to 40 people, including 9 prime oncologists from Jordan and the Managing Director of the Frankfurt Innovation Center, Dr. Christian Garbe from Germany.
Berlin, March 22nd 2017, Ms. Rasha Oudeh CEO of Cedem AG spoke at the Arab-German Health forum, discussing Jordanian trends in the pharmaceutical industry and the new technology OptiCancer and its potential impact on future innovation.
Dubai, Janury 30th 2017. After Signing the agreement with FiZ ,OptiCancer® presented successfuly at the Arab Health Exhibition 2017, with the presence of Dr.Rotter from Germany representing FiZ and Engineer, Ms.Ferial Abu Hantash the project supervisor from Jordan .
Professor of Surgery and Surgical Oncology of the University of Cairo, Dr. Gamal Mostafa Saied joins the OptiCancer club.
Ms. Rasha Oudeh CEO of Cedem AG and Dr. Gamal discussed the concept of OptiCancer and the potential impact it could have on cancer treatment in the MENA region.
Amman, March 5th, 2017, Dr. Sami Al- Khatib, President of the Arab Collaborative Hematology and Oncology Group, and Secretary General of the Arab Medical Association Against Cancer, joined the OptiCancer Club.
Frankfurt, January 17th, 2017 – The FIZ Frankfurt Biotechnology Innovation Center and its German Genethics Network partners entered a partnership with CEDEM AG Germany. As a pioneer company working in healthcare sector, CEDEM AG will represent FIZ in the MENA region.
Amman, March 19th 2017, Cedem AG's team, Ms. Sally Quzmar and Ms. Razan Ammari carried out a round table discussion with chest and ENT doctors.
Dr. Abdelrahman Anani, pulmonologist and member of both the British and Jordanian Thorax society joined the OptiCancer club, after being present at the discussion.